====== CGAB 501: Class Schedule ======
~~NOCACHE~~
//
//
**JME**
: John Essigmann
**RS**
: Ram Sasisekharan
**UN**
: Uma Narayanasami
**MF**
: Mayuree Fuangthong
----
^ Date/Time ^ Topics ^ Lecturer ^
| **Mon 09 Jun 2014** \\ 09:00 - 12:00 | \\ **L1: Molecular Level: Central Dogma & Replication** \\ -Central dogma and nucleic acid structure\\ -DNA Replication\\ | \\ MF \\ \\ \\ |
| **Wed 11 Jun 2014** \\ 09:00 - 12:00 | \\ **L2: Molecular Level: Transcription**\\ • Transcription machinery\\ • Transcription regulation | \\ MF |
| **Fri 13 Jun 2013** \\ 09:00 - 12:00 | \\ **L3: Molecular Level: Translation**\\ • Translation machinery\\ • Stages in translation | \\ MF |
| **Mon 16 Jun 2014** \\ 09:00 - 12:00\\ | \\ **L4: Molecular Level: Spontaneous and Induced Mutations as Drivers of Evolution**\\ • Introduction into Core Curriculum and CGAB501: The MIT perspective\\ • Research paper topic: Inflammation and Cancer\\ • Example: Hepatitis B and Aflatoxin (which will be covered in more detail later)\\ | \\ JME |
| 13:00 - 16:00 | **Review 1** | MF |
| **Wed 18 Jun 2014** \\ 09:00 - 12:00\\ \\ \\ | \\ **L5: Molecular Level: Spontaneous and Induced Mutations as Drivers of Evolution**\\ • Spontaneous and induced mutations\\ • Mutator phenotype and cancer | \\ JME\\ \\ \\ |
| **Fri 20 Jun 2014** \\ 09:00 - 12:00\\ | \\ **L6: Molecular Level: MMR and Evolution**\\ • Mismatch repair and fast forward evolution\\ • Drug resistance driven by fast evolution\\ • Paper analysis (Arkin; Loeb) | \\ JME |
| **Mon 23 Jun 2014** \\ 09:00 - 12:00 | \\ **L7: Molecular Level: Cancer**\\ • Six steps of malignant transformation\\ • How conventional anticancer drugs target molecular pathways\\ • Review of molecular pathways of growth and energy metabolism\\ • Recent advances showing that specific metabolic networks of cancer cells determine\\ susceptibility to anticancer agents | \\ JME |
| 13:00 - 16:00 | **Review 2** | JME/MF/TA |
| **Wed 25 Jun 2014** \\ 09:00 - 12:00 | \\ **L8: Molecular Level: Cancer**\\ • Metabolic networks of cancer and other growing cells\\ • Paper analysis (Ditsworth, Dawson) | \\ JME |
| **Fri 27 Jun 2014** \\ 09:00 - 12:00\\ | \\ **L9: Cell Level: Innate Immunity 1**\\ • Activation of innate immune system accelerates cancer development\\ • Chemistry of inflammation | \\ JME |
| **Mon 30 Jun 2014** \\ 09:00 - 12:00 | \\ **L10: Cell Level: Innate Immunity 2**\\ • Activation of innate immune system accelerates cancer development\\ • Chemistry of inflammation| \\ JME |
| **Tue 1 Jul 2014** \\ 09:00 - 12:00 | **Review 3** | JME |
| **Wed 2 Jul 2014** \\ 09:00 - 12:00 | \\ **L11: Cell Level to Organ Level**\\ • Aflatoxin carcinogenesis as a paradigm in which inflammation by an infectious agent (Hepatitis B)\\ accelerates cancer initiated by a chemical (Aflatoxin)\\ | \\ JME |
| **Fri 4 Jul 2014** \\ 09:00 - 12:00 | \\ **L12: Synergy and sensitivity modulation in biological networks**\\ | \\ JME |
| **Tue 15 Jul 2014** \\ 09:00 - 12:00 | \\ **L13: How to Identify a Functional Biomarker: A Case Study Involving Aflatoxin B1 and HBV**\\ | \\ SC |
| **Mon 21 Jul 2014** \\ 09:00 - 12:00 | \\ **Exam I** | \\ Staff |
| **Tue 22 Jul 2014** \\ 13:00 - 16:00 | \\ **L14: Cells to Tissues**\\ • Extracellular Matrix| \\ RS |
| **Wed 23 Jul 2014** \\ 09:00 - 12:00 | \\ **L15: Cancer at the Clinical Level**\\ • Hematology and Oncology | \\ UN |
| **Fri 25 Jul 2014** \\ 09:00 - 12:00 | \\ **L16: Cancer at the Clinical Level** | \\ UN |
| **Mon 28 Jul 2014** \\ 09:00 - 12:00 | \\ **L17: Cancer at the Clinical Level** | \\ UN |
| **Wed 30 Jul 2014** \\ 09:00 - 12:00 | \\ **L18: Cancer at the Clinical Level** | \\ UN |
| **Fri 01 Aug 2014** \\ 09:00 - 12:00 | \\ **L19: Cancer at the Clinical Level** | \\ UN |
| **Late Aug** \\ 09:00 - 12:00 | \\ **Proposal Presentation I** | \\ Staff |
| **Late Sep** \\ 09:00 - 12:00 | \\ **Proposal Presentation II** | \\ Staff |
| **Late Oct** \\ 13:00 - 16:00 | \\ **Proposal Presentation III** | \\ Staff |
| **Mon 18 Aug 2014** \\ 09:00 - 12:00 | \\ **Exam II** | \\ Staff |